Resultados de procura - Laura Torchen

  • Mostrando 1 - 6 Resultados de 6
Limitar resultados
  1. 1
    Cardiometabolic Risk in PCOS: More than a Reproductive Disorder

    Cardiometabolic Risk in PCOS: More than a Reproductive Disorder por Laura Torchen

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Distinctive Reproductive Phenotypes in Peripubertal Girls at Risk for Polycystic Ovary Syndrome

    Distinctive Reproductive Phenotypes in Peripubertal Girls at Risk for Polycystic Ovary Syndrome por Laura Torchen, Richard S. Legro, Andrea Dunaif

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome

    Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome por Laura Torchen, Jan Idkowiak, Naomi Fogel, Donna O’Neil, Cedric Shackleton, Wiebke Arlt, Andrea Dunaif

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Distinct Reproductive Phenotypes Segregate With Differences in Body Weight in Adolescent Polycystic Ovary Syndrome

    Distinct Reproductive Phenotypes Segregate With Differences in Body Weight in Adolescent Polycystic Ovary Syndrome por Angie Chen-Patterson, Angelina Bernier, Tania S. Burgert, Vanessa Davis, T. Khan, David A. Geller, Emily Paprocki, Rachana Shah, Selma F. Witchel, Camila Pereira-Eshraghi, Aviva B. Sopher, Melanie Cree‐Green, Laura Torchen

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife

    Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife por Monika Sarkar, Melissa Wellons, Marcelle I. Cedars, Lisa B. VanWagner, Erica P. Gunderson, Veeral Ajmera, Laura Torchen, David S. Siscovick, J. Jeffrey Carr, James G. Terry, Mary E. Rinella, Cora E. Lewis, Norah A. Terrault

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial

    Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial por Elizabeth Roof, Cheri Deal, Shawn E. McCandless, Ronald L. Cowan, Jennifer Miller, Jill Hamilton, Elizabeth Roeder, Shana E. McCormack, Tamanna Roshan Lal, Hussein Abdullatif, Andrea M. Haqq, Kathryn Obrynba, Laura Torchen, Alaina P. Vidmar, David Viskochil, Jean‐Pierre Chanoine, Carol Lam, Melinda Pierce, Laurel L. Williams, Lynne M. Bird, Merlin G. Butler, D. E. Jensen, S Myers, Oliver Oatman, Charumathi Baskaran, Laura Chalmers, Cary Fu, Nathalie Alos, Scott D. McLean, Ajay M. Shah, Barbara Y. Whitman, Brent A. Blumenstein, Sarah F Leonard, Jessica P Ernest, Joseph W. Cormier, Sara P. Cotter, Davis C. Ryman

    Publicado 2023
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: